Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea.
Surg Endosc. 2012 Nov;26(11):3293-300. doi: 10.1007/s00464-012-2343-z. Epub 2012 May 31.
Perforation after endoscopic retrograde cholangiopancreatography (ERCP) is a rare but severe complication. The purpose of this study was to assess the clinical outcomes with perforations after ERCP from a large number of cases.
Among 11,048 patients who underwent ERCP during 10 years, medical records from 68 patients (0.62 %) who experienced post-ERCP perforation with radiologic, endoscopic, or surgical evidence were retrospectively reviewed. We assessed the clinical outcomes of patients and analyzed the factors associated with poor outcomes, which were defined as mortality, prolonged hospital stay due to complications, or loss of chance of cure in the case of cancer.
Twenty-nine patients were male, and the median age was 65.0 years. Therapeutic ERCP was performed in 52 cases (77 %). Common mechanisms of perforation were endoscopic sphincterotomy (37 %), catheter or guidewire (34 %), and endoscope (19 %). In contrast to 9 patients who underwent emergent operation, 59 patients (87 %) were conservatively treated. In 44 patients, perforation was detected during the procedure; however, detection after 24 h or permitted oral intake before detection occurred in 18 cases (27 %). Although 58 patients recovered without poor outcomes, 10 patients (15 %) experienced poor outcomes, which consisted of mortality (n = 4), loss of chance of cure (n = 2), and prolonged hospital stay without surgery more than 1 month due to complications (n = 4). By multiple logistic regression analysis, perforation by endoscope and rebound tenderness was statistically associated with poor outcomes (odds ratio: 13.7 and 7.3, respectively).
Most patients fully recovered from perforation; however, some patients experienced grave outcomes, including mortality. Perforation by endoscope and rebound tenderness was significantly associated with poor outcomes.
内镜逆行胰胆管造影(ERCP)后穿孔是一种罕见但严重的并发症。本研究旨在评估大量病例中 ERCP 后穿孔的临床结果。
在 10 年期间接受 ERCP 的 11048 例患者中,回顾性分析了 68 例(0.62%)经影像学、内镜或手术证实存在 ERCP 后穿孔的患者的病历。我们评估了患者的临床结果,并分析了与不良结果相关的因素,不良结果定义为死亡、因并发症延长住院时间或癌症患者丧失治愈机会。
29 例患者为男性,中位年龄为 65.0 岁。52 例(77%)进行了治疗性 ERCP。穿孔的常见机制为内镜下括约肌切开术(37%)、导管或导丝(34%)和内镜(19%)。与 9 例紧急手术患者相比,59 例(87%)患者接受了保守治疗。在 44 例患者中,穿孔在操作过程中被发现;然而,在 18 例(27%)中,穿孔是在 24 小时后或在检测前允许口服摄入时被发现的。尽管 58 例患者无不良后果恢复,但 10 例(15%)患者出现不良后果,包括死亡(n=4)、丧失治愈机会(n=2)和因并发症导致的手术外住院时间延长 1 个月以上(n=4)。通过多变量逻辑回归分析,内镜穿孔和反跳痛与不良结果具有统计学相关性(比值比分别为 13.7 和 7.3)。
大多数患者的穿孔完全愈合;然而,一些患者出现严重后果,包括死亡。内镜穿孔和反跳痛与不良结果显著相关。